Dror Ortho-Design, Inc. financial data

Symbol
DROR on OTC
Industry
Dental Equipment & Supplies
Location
480 Johnson Road, Suite 200, Washington, PA
State of incorporation
DE
Fiscal year end
December 31
Former names
NOVINT TECHNOLOGIES INC (to 8/14/2023)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 538 % +223%
Debt-to-equity 23 % -73.1%
Return On Equity -364 % -81.9%
Return On Assets -296 % -111%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 957M shares
Common Stock, Shares, Outstanding 957M shares +93.2%
Entity Public Float 4.31M USD -53.9%
Common Stock, Value, Issued 95.7K USD +93.2%
Weighted Average Number of Shares Outstanding, Basic 738M shares +138%
Weighted Average Number of Shares Outstanding, Diluted 738M shares +138%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 1.45M USD +38.6%
General and Administrative Expense 1.6M USD +38.2%
Operating Income (Loss) -7.15M USD -171%
Nonoperating Income (Expense) -9.87K USD -188%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -6.91M USD -164%
Net Income (Loss) Attributable to Parent -6.91M USD -266%
Earnings Per Share, Basic -0.01 USD/shares
Earnings Per Share, Diluted -0.01 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.83M USD +6640%
Assets, Current 1.24M USD -70.2%
Property, Plant and Equipment, Net 25.4K USD +917%
Assets 1.27M USD -69.6%
Accounts Payable, Current 84.7K USD +1353%
Accrued Liabilities, Current 592 USD +0.34%
Liabilities, Current 888K USD -9.47%
Other Liabilities, Noncurrent 5.13K USD
Liabilities 893K USD -8.98%
Retained Earnings (Accumulated Deficit) -18.4M USD -60.2%
Stockholders' Equity Attributable to Parent 374K USD -88.2%
Liabilities and Equity 1.27M USD -69.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -781K USD +1.56%
Net Cash Provided by (Used in) Investing Activities -16.7K USD
Common Stock, Shares Authorized 3.25B shares +551%
Common Stock, Shares, Issued 957M shares +93.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -798K USD -0.56%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.14M USD -71.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 14 USD -73.6%
Deferred Tax Assets, Valuation Allowance 9.95M USD +374%
Depreciation 466 USD +179%
Payments to Acquire Property, Plant, and Equipment 16.7K USD
Deferred Tax Assets, Operating Loss Carryforwards 9.24M USD +356%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 12.5M shares 0%
Unrecognized Tax Benefits 2.05M USD
Additional Paid in Capital 18.7M USD +27.7%
Preferred Stock, Shares Outstanding 5.85M shares -44.1%
Deferred Tax Assets, Net of Valuation Allowance 9.95M USD +374%
Share-based Payment Arrangement, Expense 4.1M USD +21486%
Interest Expense 168 USD -25.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%